Company profile for Alchemab

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At Alchemab, we are harnessing the power of our immune system to cure disease We turn drug discovery on its head by using nature’s most effective search engine: adaptive immunity We identify “elite controllers” – or especially resilient individuals – and learn how they overcome or resist disease. Using cutting-edge science and deep learning, we turn antibodies into therapeutics We have a range of programmes across...
At Alchemab, we are harnessing the power of our immune system to cure disease We turn drug discovery on its head by using nature’s most effective search engine: adaptive immunity We identify “elite controllers” – or especially resilient individuals – and learn how they overcome or resist disease. Using cutting-edge science and deep learning, we turn antibodies into therapeutics We have a range of programmes across cancers, neurodegenerative conditions and infectious diseases

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
55-56 Russell Square London WC1B 4HP
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/alchemab-therapeutics-initiates-phase-1-clinical-trial-of-atlx-1282-and-announces-series-a-financing-extension-302549523.html

PR NEWSWIRE
09 Sep 2025

https://www.fiercebiotech.com/biotech/eli-lilly-licenses-early-stage-als-drug-program-alchemab-415m-pact

FIERCE PHARMA
07 May 2025

https://www.prnewswire.com/news-releases/alchemab-therapeutics-enters-into-collaboration-with-lilly-to-discover-research-and-develop-novel-therapies-for-als-302346205.html

PR NEWSWIRE
09 Jan 2025

https://www.prnewswire.com/news-releases/alchemab-appoints-co-founder-jane-osbourn-as-chief-executive-officer-302246428.html

PR NEWSWIRE
12 Sep 2024

https://www.prnewswire.com/news-releases/alchemab-advances-a-novel-antibody-with-potential-in-parkinsons-disease-with-support-from-the-michael-j-fox-foundation-302165114.html

PR NEWSWIRE
06 Jun 2024

https://www.pharmiweb.com/press-release/2024-05-15/publication-in-nature-immunology-outlining-the-contribution-of-b-cells-to-anticancer-immunosurveillance-highlights-alchemab-s-capabilities-and-potenti

PHARMIWEB
15 May 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty